Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2012
07/05/2012US20120172342 Biotherapeutics For the Treatment of Infectious Diseases
07/05/2012US20120172341 Compositions comprising tramadol and celecoxib in the treatment of pain
07/05/2012US20120172340 Compositions and Methods for Selectively Activating Human Sirtuins
07/05/2012US20120172339 Angiogenic resorcinol derivatives
07/05/2012US20120172338 Topical gel formulation comprising organophosphate insecticide and its preparation thereof
07/05/2012US20120172337 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
07/05/2012US20120172336 Fosfluconazole Derivatives, Synthesis, and Use in Long Acting Formulations
07/05/2012US20120172335 Substituted benzimidazolone derivatives, medicaments comprising them and their use
07/05/2012US20120172333 Pyrrolo-pyridine derivatives as activators of ampk
07/05/2012US20120172332 Antibacterial aminoglycoside analogs
07/05/2012US20120172331 Methods of using human milk oligosaccharides for improving airway respiratory health
07/05/2012US20120172330 Human milk oligosaccharides for modulating inflammation
07/05/2012US20120172329 Phytochemical compositions including xanthones for anti-inflammatory, anti-cytokine storm, and other uses
07/05/2012US20120172327 Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
07/05/2012US20120172326 Moisturizing Mixture, Cosmetic And/Or Pharmaceutical Compositions Containing The Moisturizing Mixture, Use Of The Moisturizing Mixture, And Cosmetic Method
07/05/2012US20120172325 Methods and Compositions for the Treatment of Gastrointestinal Disorders
07/05/2012US20120172324 Compositions and methods for reducing the risk of agent-induced liver toxicity
07/05/2012US20120172323 Methods for treating malaria, tuberculosis and mac diseases
07/05/2012US20120172321 Hsp90 inhibitors
07/05/2012US20120172320 Compositions comprising and methods of using inhibitors of sodium-glucose cotransporters 1 and 2
07/05/2012US20120172319 Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
07/05/2012US20120172307 Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
07/05/2012US20120172292 Method for protection of antimicrobial and anticancer drugs from inactivation by nitric oxide
07/05/2012US20120172290 Anti-Viral Compounds
07/05/2012US20120172289 Multifunctional glycopeptide antibiotic derivatives for fluorescent imaging and photoactive antimicrobial therapy
07/05/2012US20120172283 Methods and compositions for targeted drug delivery
07/05/2012US20120172227 5-aminolevulinic acid salt, process for producing the same and use thereof
07/05/2012US20120172217 Pesticidal compositions
07/05/2012US20120171504 Single step creosote/borate wood treatment
07/05/2012US20120171311 Substances for reducing occurrence of major cardiac events comprising epa or derivatives thereof, optionally, dha or derivatives thereof and monacolin k
07/05/2012US20120171310 Plant essential oil-based antimicrobial fish filming compositions and methods of use
07/05/2012US20120171309 Formulations and methods for increasing efficacies and improving flavors of formulations containing gynostemma plant
07/05/2012US20120171308 Antioxidant Complex, Cosmetic and Pharmaceutical Compositions Containing Said Complex, and Use of Said Complex
07/05/2012US20120171307 Magnesium Compositions and Uses Thereof for Neurological Disorders
07/05/2012US20120171306 Therapeutic treatment of cancer and dysplasia of the cervix or vagina using estrogen antagonists
07/05/2012US20120171305 Response Prediction in Cancer Treatment Involving p53 Adapted Cancer Therapy
07/05/2012US20120171304 Stabilized Aptamers To Platelet Derived Growth Factor And Their Use As Oncology Therapeutics
07/05/2012US20120171303 Compositions and methods for ehnancing cognitive and related functions in animals
07/05/2012US20120171302 Compositions and methods for inhibiting redox-sensitive gtpases
07/05/2012US20120171297 Threo-dops controlled release formulation
07/05/2012US20120171296 Rapidly disintegrating solid preparation
07/05/2012US20120171289 Delivery systems for bioactive agents
07/05/2012US20120171288 Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine, their preparation and their therapeutic application
07/05/2012US20120171286 Methods and compositions for the treatment and diagnosis of statin-induced myopathy
07/05/2012US20120171284 Celecoxib compositions
07/05/2012US20120171283 Liposomes Useful for Drug Delivery
07/05/2012US20120171282 Ginkgo biloba extract with a standardised ginkgo flavone glycosides content deprived of the paf-antagonist terpenic fraction, and compositions containing it, for the prevention and treatment of circulatory, cognitive, geriatric and sensory disorders
07/05/2012US20120171281 Novel Formulations of Volatile Anesthetics and Methods of Use for Reducing Inflammation
07/05/2012US20120171280 Method of making liposomes, liposome compositions made by the methods, and methods of using the same
07/05/2012US20120171279 Strongly bound base-modified oligonucleotides
07/05/2012US20120171278 Percutaneous absorption type plaster
07/05/2012US20120171275 Local administration of gallium compositions to treat pain
07/05/2012US20120171274 Transdermal patch
07/05/2012US20120171273 Oral compositions for skin benefits
07/05/2012US20120171262 Pharmaceutical formulations
07/05/2012US20120171261 Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles and their use for diagnostics and therapy
07/05/2012US20120171256 Electrospun silk material systems for wound healing
07/05/2012US20120171254 Process and Apparatuses for Preparing Nanoparticle Compositions with Amphiphilic Copolymers and Their Use
07/05/2012US20120171252 Oil-in-water emulsion of mometasone and propylene glycol
07/05/2012US20120171249 Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
07/05/2012US20120171248 Compounds and methods for immunotherapy and diagnosis of tuberculosis
07/05/2012US20120171245 Inhibitors of influenza viruses replication
07/05/2012US20120171236 Immunization against chlamydia pneumoniae
07/05/2012US20120171228 Anti-cancer regimen
07/05/2012US20120171227 Pro-drug complexes and related methods of use
07/05/2012US20120171222 Methods and compositions involving nucleotide repeat disorders
07/05/2012US20120171221 Biomarkers for the early detection of autoimmune diseases
07/05/2012US20120171220 Further use of protein kinase n beta
07/05/2012US20120171219 Use of pkc-zeta as a breast cancer tumorigenic biomarker as well as a target for treatment of breast cancer
07/05/2012US20120171215 Nogo-a binding molecules and pharmaceutical use thereof
07/05/2012US20120171213 Method of treating tumors
07/05/2012US20120171201 Methods of treating her2 positive cancer with her2 receptor antagonist in combination with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin
07/05/2012US20120171199 Tricyclic pi3k inhibitor compounds and methods of use
07/05/2012US20120171192 Methods and materials for modulating deubiquitinases and ubiquitinated polypeptides
07/05/2012US20120171191 Meganuclease variants cleaving the genome of a pathogenic non-integrating virus and uses thereof
07/05/2012US20120171186 method for producing a nutraceutical composition and the nutraceutical produced by the method
07/05/2012US20120171170 Treatment of collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene
07/05/2012US20120171166 Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
07/05/2012US20120171165 Human milk oligosaccharides to promote growth of beneficial bacteria
07/05/2012US20120171158 METHODS OF USING sIP-10, CD26 INHIBITORS AND CXCR3 LEVELS IN A SAMPLE TO ASSESS CLEARANCE OF INFECTION, RESPONSE TO INTERFERON THERAPY, AND TREATING CHRONIC INFECTIONS
07/05/2012US20120171157 Macrocyclic Inhibitors Of Hepatitis C Virus
07/05/2012US20120171156 Methods and compounds for reducing allergic reactions to hair dyes
07/05/2012US20120171154 purification of multi-specific receptors
07/05/2012US20120171152 Amphiphilic Polymer-Protein Conjugates and Methods of Use Thereof
07/05/2012US20120171151 Mass spectrometric quantitation assay for metabolites of leflunomide
07/05/2012US20120171150 Ion Bonding Pharmaceutical Composition
07/05/2012US20120171129 Inhibition and Dispersion of Bacterial Biofilms with Benzimidazole Derivatives
07/05/2012US20120171126 NOVEL [3,2-c] HETEROARYL STEROIDS AS GLUCOCORTICOID RECEPTOR AGONISTS COMPOSITIONS AND USES THEREOF
07/05/2012US20120171125 Methods for Enhancing the Cognitive Function
07/05/2012US20120171123 Uses and compositions for treatment of rheumatoid arthritis
07/05/2012US20120171118 Treatment of meningeal and neural diseases
07/05/2012US20120171116 Arginase Inhibitors and Methods of Use Thereof
07/05/2012US20120171076 Water temperature as a means of controlling kinetics of onsite generated peracids
07/05/2012US20120168335 Fast Disintegrating Compositions of Meloxicam, Processes for Preparation, and Use to Treat Arthritis and/or Pain
07/05/2012DE102011000020A1 Wirkstoff, der Indocyaningrün und/oder Infracyaningrün enthält Contains active substance, the indocyanine green and / or Infracyaningrün
07/05/2012DE102010056610A1 Pharmazeutische Zusammensetzung enthaltend L-DNA A pharmaceutical composition comprising L-DNA
07/05/2012CA2845505A1 Substituted hydrogenated thieno-pyrrolo[3,2-c]pyridine, ligands, a pharmaceutical composition and a method for using the above
07/05/2012CA2823512A1 Granulates comprising eslicarbazepine acetate
07/05/2012CA2823401A1 Therapeutic compounds and compositions
07/05/2012CA2823355A1 Nanoparticle and surface-modified particulate coatings, coated balloons, and methods therefore
1 ... 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 ... 7860